Nemaura Medical INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Nemaura Medical reports a net loss for Q3 2024, continues to advance its sugarBEAT device, and shifts its FDA strategy.